Mitochondria-targeted antioxidants as promising drugs for treatment of age-related brain diseases

Journal of Alzheimer's Disease

Volumn 28, Issue 2, 2012, Pages 283-289

  Skulachev, Vladimir P ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Alzheimer's disease; behavior; hippocampus; mitochondria targeted antioxidant; plastoquinone; stroke

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; GLYCOGEN SYNTHASE KINASE 3BETA; MEMBRANE PROTEIN; PROTEIN RCNA1; REACTIVE OXYGEN METABOLITE; SKQ1; SUPEROXIDE DISMUTASE; TAU PROTEIN; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BRAIN REGION; DISEASE COURSE; ELECTRIC ACTIVITY; FOOD INTAKE; HIPPOCAMPUS; MITOCHONDRION; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 84857029496     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-111391     Document Type: Article

References (48)

1. Skulachev VP (2003) Aging and the programmed death phenomena. In Topics in Current Genetics, Vol. 3. Nystrom T, Osiewacz HD, Eds. Model systems in ageing. SpringerVerlag, Berlin Heidelberg, pp. 191-238.
2. Skulachev VP, Longo VD (2005) Aging as a mitochondria-mediated atavistic program: Can aging be switched off? Ann N Y Acad Sci 1057, 145-164. (Pubitemid 43211632)
3. Longo VD, Mitteldorf J, Skulachev VP (2005) Programmed and altruistic ageing. Nat Rev Gene 6, 866-872.
4. Pagani L, Eckert A (2011) Amyloid-Beta interaction with mitochondria. Int J Alzheimers Dis 2011, 925050.
5. GoldsteinN (2002) Reactive oxygen species as essential components of ambient air. Biochemistry (Mosc) 67, 161-170. (Pubitemid 34474089)
6. Antonenko YN, Avetisyan AV, Bakeeva LE, Chernyak BV, Chertkov VA, Domnina LV, Ivanova OY, Izyumov DS, Khailova LS, Klishin SS, Korshunova GA, Lyamzaev KG, Muntyan MS, Nepryakhina OK, Pashkovskaya AA, Pletjushkina OY, Pustovidko AV, Roginsky VA, Rokitskaya TI, Ruuge EK, Saprunova VB, Severina II, Simonyan RA, Skulachev IV, Skulachev MV, Sumbatyan NV, Sviryaeva IV, Tashlitsky VN, Vassiliev JM, Vyssokikh MY, Yaguzhinsky LS, Zamyatnin AA Jr, Skulachev VP (2008) Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: Synthesis and in vitro studies. Biochemistry (Mosc) 73, 1273-1287.
7. Liberman EA, Topaly VP, Tsofina LM, Jasaitis AA, Sku-lachev VP (1969) Mechanism of coupling of oxidative phosphorylation and the membrane potentialofmitochondria. Nature 222, 1076-1078.
8. Skulachev VP, Anisimov VN, Antonenko YN, Bakeeva LE, Chernyak BV, Erichev VP, Filenko OF, Kalinina NI, Kapelko VI, Kolosova NG, Kopnin BP, Korshunova GA, Lichinitser MR, Obukhova LA, Pasyukova EG, Pisarenko OI, Roginsky VA, Ruuge EK, Senin II, Severina II, Skulachev MV, Spivak IM, Tashlitsky VN, Tkachuk VA, Vyssokikh MY, Yaguzhin-sky LS, Zorov DB (2009) An attempt to prevent senescence: A mitochondrial approach. Biochim Biophys Acta 1787, 437-461.
9. Severin FF, Severina II, Antonenko YN, Rokitskaya TI, Cherepanov DA, Mokhova EN, Vyssokikh MY, Pustovidko AV, Markova OV, Yaguzhinsky LS, Korshunova GA, Sum-batyan NV, Skulachev MV, Skulachev VP (2010) Penetrating cation/fatty acid anion pair as a mitochondria-targeted protonophore. Proc Natl Acad Sci U S A 107, 663-668.
10. Antonenko YN, Avetisyan AV, Cherepanov DA, Knorre DA, Korshunova GA, Markova OV, Ojovan SM, Perevoshchikova IV, Pustovidko AV, Rokitskaya TI, Severina II, Simonyan RA, Smirnova EA, Sobko AA, Sumbatyan NV, Severin FF, Skulachev VP (2011) Derivatives of Rhodamine 19 as mild mitochondria-targeted cationic uncouplers. J Biol Chem 286, 17831-17840.
11. Korshunov SS, Skulachev VP, Starkov AA (1997) High pro-tonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 416, 15-18. (Pubitemid 27470791)
12. Skulachev MV, Antonenko YN, Anisimov VN, Chernyak BV, Cherepanov DA, Chistyakov VA, Egorov MV, Kolosova NG, Korshunova GA, Lyamzaev KG, Plotnikov EY, Rogin-sky VA, Savchenko AY, Severina II, Severin FF, Shkurat TP, Tashlitsky VN, Shidlovsky KM, Vyssokikh MY, Zamyatnin AA Jr, Zorov DB, Skulachev VP (2011) Mitochondrial-targeted plastoquinone derivatives. Effect on senescence and acute age-related pathologies. Curr Drug Targets 12, 800-826.
13. Plotnikov EY, Silachev DN, Chupyrkina AA, Danshina MI, Jankauskas SS, Morosanova MA, Stelmashook EV, Vasileva AK, Goryacheva ES, Pirogov YA, Isaev NK, Zorov DB (2010) New-generation Skulachev ions exhibiting nephroprotective and neuroprotective properties. Biochemistry (Mosc) 75, 145-150.
14. Silachev DN, Pevzner IB, Zorova LD, Plotnokov EY, Gulyaev VV, Pirogov YA, Isaev NK, Skulachev VP, Zorov DB (2011) New generation of penetrating cations as potential agents to rescue from ischemic stroke. FEBS J 278 (Suppl.1), 280.
15. Stefanova NA, Fursova AZh, Kolosova NG (2010) Behavioral effects induced by mitochondria-targeted antioxidant SkQ1 in Wistar and senescence-accelerated OXYS rats. J Alzheimers Dis 21, 479-491.
16. Hopkin K (2003) Dietary drawbacks. Sci Aging Knowledge Environ 8, NS4.
17. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791. (Pubitemid 35231524)
18. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421. (Pubitemid 36937044)
19. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8, 101-112. (Pubitemid 46432529)
20. Malenka RC, Nicoll RA (1999) Long-term potentiation: A decade of progress? Science 285, 1870-1874.
21. Kapay NA, Isaev NK, Stelmashook EV, Popova OV, Zorov DB, Skrebitsky VG, Skulachev VP (2011) In vivo injected mitochondriatargeted plastoquinone antioxidant SkQR1 prevents ßamyloidinduced decay of longterm potentiation in rat hippocampal slices. Biochemistry (Mosc) 76, 1695-1699.
22. Ma T, Hoeffer CA, Wong H, Massaad CA, Zhou P, Iadecola C, Murphy MP, Pautler RG, Klann E (2011) Amyloid ß-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide. JNeurosci 31, 5589-5595.
23. Manczak M, Mao P, Calkins MJ, Cornea A, Reddy AP, Murphy MP, Szeto HH, Park B, Reddy PH (2010) Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons. J Alzheimers Dis 20 (Suppl 2), S609-631.
24. Murphy MP, Smith RA (2007) Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 47, 629-656.
25. Snow BJ, Rolfe FL, Lockhart MM, Frampton CM, O'Sullivan JD, Fung V, Smith RA, Murphy MP, Taylor KM, Protect Study, Group (2010) A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease. Mov Disord 25, 1670-1674.
26. Tauskela JS (2007) MitoQ-a mitochondria-targeted antioxidant. I Drugs 10, 399-412.
27. Smith MA, Richey PL, Taneda S, Kutty RK, Sayre LM, Mon-nier VM, Perry G (1994) Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease. Ann N Y Acad Sci 738, 447-454.
28. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996) Oxidative damage in Alzheimer's. Nature 382, 120-121.
29. Kadowaki H, Nishitoh H, Urano F, Sadamitsu C, Matsuzawa A, Takeda K, Masutani H, Yodoi J, Urano Y, Nagano T, Ichijo H (2005) Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ 12, 19-24. (Pubitemid 40090025)
30. Tabner BJ, El-Agnaf OM, Turnbull S, German MJ, Paleol-ogou KE, Hayashi Y, Cooper LJ, Fullwood NJ, Allsop D (2005) Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia. J Biol Chem 280, 35789-35792. (Pubitemid 41633844)
31. Atamna H, Boyle K (2006) Amyloid-beta peptide binds with heme to form a peroxidase: Relationship to the cytopatholo-gies of Alzheimer's disease. Proc Natl Acad Sci USA 103, 3381-3386. (Pubitemid 43346478)
32. Radak Z, Kumagai S, Taylor AW, Naito H, Goto S (2007) Effects of exercise on brain function: Role of free radicals. Appl Physiol Nutr Metab 32, 942-946.
33. Kwon KJ, Kim HJ, Shin CY, Han SH (2010) Melatonin potentiates the neuroprotective properties of resveratrol against beta-amyloid-induced neurodegeneration by modulating AMP-activated protein kinase pathways. J Clin Neurol 6, 127-137.
34. Li J, Dong Z, Liu B, Zhuo Y, Sun X, Yang Z, Ge J, TanZ (2011) Hypoxia induces beta-amyloid in association with death of RGC-5 cells in culture. Biochem Biophys Res Commun 410, 40-44.
35. Tillement L, Lecanu L, Papadopoulos V (2011) Alzheimer's disease: Effects of ß-amyloid on mitochondria. Mitochondrion 11, 13-21.
36. Cardoso SM, Swerdlow RH, Oliveira CR (2002) Induction of cytochrome c-mediated apoptosis by amyloid beta 25-35 requires functional mitochondria. Brain Res 931, 117-125. (Pubitemid 34230515)
37. Yan SD, Xiong WC, Stern DM (2006) Mitochondrial amyloid-beta peptide: Pathogenesis or late-phase development? J Alzheimers Dis 9, 127-137. (Pubitemid 44078640)
38. Newington JT, Pitts A, Chien A, Arseneault R, Schubert D, Cumming RC (2011) Amyloid beta resistance in nerve cell lines is mediated by the Warburg effect. PLoS One 6, e19191.
39. Caspersen C, Wang N, Yao J, Sosunov A, Chen X, Lustbader JW, Xu HW, Stern D, McKhann G, Yan SD (2005) Mitochondrial Abeta: A potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J19, 2040-2041. (Pubitemid 41759758)
40. Barsoum MJ, Yuan H, Gerencser AA, Liot G, Kushnareva Y, Gräber S, Kovacs I, Lee WD, Waggoner J, Cui J, White AD, Bossy B, Martinou JC, Youle RJ, Lipton SA, Ellisman MH, Perkins GA, Bossy-Wetzel E (2006) Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J 25, 3900-3911. (Pubitemid 44300275)
41. Veereshwarayya V, Kumar P, Rosen KM, Mestril R, Quer-furth HW (2006) Differential effects of mitochondrial heat shock protein 60 and related molecular chaperones to prevent intracellular beta-amyloid-induced inhibition of complex IV and limit apoptosis. J Biol Chem 281, 29468-29478. (Pubitemid 44536955)
42. Butterfield DA, Perluigi M, Sultana R (2006) Oxidative stress in Alzheimer's disease brain: New insights from redox pro-teomics. Eur J Pharmacol 545, 39-50. (Pubitemid 44215876)
43. Ferreira IL, Resende R, Ferreiro E, Rego AC, Pereira CF (2010) Multiple defects in energy metabolism in Alzheimer's disease. CurrDrug Targets 11, 1193-1206.
44. Lloret A, Badía MC, Mora NJ, Ortega A, Pallardó FV, Alonso MD, Atamna H, Vina J (2008) Gender and age-dependent differences in the mitochondrial apoptogenic pathway in Alzheimer's disease. Free Radic Biol Med 44, 2019-2025.
45. Lloret A, Badia MC, Giraldo E, Ermak G, Alonso MD, Pallardo FV, Davies KJA, Vina J Alzheimer's amyloid-ß toxicity and tau hyperphosphorylation are linked via RCAN1. J Alzheimers Dis 27, 701-709.
46. Skulachev VP, Antonenko YN, Cherepanov DA, Chernyak BV, Izyumov DS, Khailova LS, Klishin SS, Korshunova GA, Lyamzaev KG, Pletjushkina OY, Roginsky VA, Rokitskaya TI, Severin FF, Severina II, Simonyan RA, Skulachev MV, Sumbatyan NV, Sukhanova EI, Tashlitsky VN, Trendeleva TA, Vyssokikh MY, Zvyagilskaya RA (2010) Prevention of cardiolipin oxidation and fatty acid cycling as two antioxidant mechanisms of cationic derivatives of plastoquinone (SkQs). Biochim Biophys Acta 1797, 878-889.
47. Lott IT, Doran E, Nguyen VQ, Tournay A, Head E, Gillen DL (2011) Down syndrome and dementia: A randomized, controlled trial of antioxidant supplementation. Am J Med Genet A 155, 1939-1948.
48. Skulachev VP (27) (2011) Mitochondria-targeted penetrating ions as inhibitors of the aging program and obesity. FEBS J 278 (Suppl.1) 39.